Elizabeth Cameron

562 total citations
18 papers, 418 citations indexed

About

Elizabeth Cameron is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Elizabeth Cameron has authored 18 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Elizabeth Cameron's work include Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Elizabeth Cameron is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Elizabeth Cameron collaborates with scholars based in United States, Canada and Netherlands. Elizabeth Cameron's co-authors include Elliot M. Frohman, Michael K. Racke, Nancy Monson, Stuart Hobbs, Robert P. Hammer, David J. Riese, F. Richard Ferraro, Doris Lambracht‐Washington, Christopher Harp and Stephanie L. Coffing and has published in prestigious journals such as Neurology, Oncogene and Biochemical Journal.

In The Last Decade

Elizabeth Cameron

17 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Cameron United States 11 183 179 111 95 93 18 418
R. Medaer Belgium 9 184 1.0× 41 0.2× 172 1.5× 33 0.3× 56 0.6× 16 352
Jacqueline Nicholas United States 12 370 2.0× 108 0.6× 67 0.6× 14 0.1× 88 0.9× 47 507
Tobias Sejbæk Denmark 12 345 1.9× 77 0.4× 84 0.8× 16 0.2× 98 1.1× 40 500
Elisabetta Verdun di Cantogno United States 11 380 2.1× 93 0.5× 38 0.3× 12 0.1× 36 0.4× 23 437
V. Devonshire Canada 3 560 3.1× 104 0.6× 65 0.6× 14 0.1× 68 0.7× 4 616
J.A.P. Hiel Netherlands 10 43 0.2× 52 0.3× 32 0.3× 21 0.2× 204 2.2× 13 350
Dan Schaid United States 7 179 1.0× 65 0.4× 115 1.0× 12 0.1× 88 0.9× 8 430
Ann Marie Weideman United States 8 252 1.4× 57 0.3× 44 0.4× 7 0.1× 61 0.7× 24 359
Frida Lundmark Sweden 7 194 1.1× 86 0.5× 269 2.4× 8 0.1× 101 1.1× 8 440
Brian Apatoff United States 8 162 0.9× 30 0.2× 122 1.1× 15 0.2× 26 0.3× 9 338

Countries citing papers authored by Elizabeth Cameron

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Cameron more than expected).

Fields of papers citing papers by Elizabeth Cameron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Cameron. The network helps show where Elizabeth Cameron may publish in the future.

Co-authorship network of co-authors of Elizabeth Cameron

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Cameron. A scholar is included among the top collaborators of Elizabeth Cameron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Cameron. Elizabeth Cameron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Curran, Dean & Elizabeth Cameron. (2025). Metcalfe’s Law and its inversion: digital network expansion and systemic risk. AI & Society. 40(6). 4575–4587.
2.
Ciciotte, Steven L., Mark D. Lessard, Ellen C. Akeson, et al.. (2014). 3-Dimensional histological reconstruction and imaging of the murine pancreas. Mammalian Genome. 25(9-10). 539–548. 3 indexed citations
3.
Ligocki, Ann J., William Rounds, Elizabeth Cameron, et al.. (2013). Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation. Genes and Immunity. 14(5). 291–301. 10 indexed citations
4.
Wilson, Kristy J., Christopher P. Mill, Richard L. Gallo, et al.. (2012). The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist. Biochemical Journal. 443(1). 133–144. 5 indexed citations
5.
Cameron, Elizabeth, et al.. (2011). Fluorescence-Labeled Reporter Gene in Transgenic Mice Provides a Useful Tool for Investigating Cutaneous Innervation. Veterinary Pathology. 49(4). 727–730. 7 indexed citations
6.
Cameron, Elizabeth, Sade Spencer, Christopher Harp, et al.. (2009). Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. Journal of Neuroimmunology. 213(1-2). 123–130. 39 indexed citations
7.
Stüve, Olaf, Petra D. Cravens, Elliot M. Frohman, et al.. (2008). Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Neurology. 72(5). 396–401. 101 indexed citations
8.
Wilson, Kristy J., Christopher P. Mill, Elizabeth Cameron, et al.. (2007). Inter-conversion of neuregulin2 full and partial agonists for ErbB4. Biochemical and Biophysical Research Communications. 364(2). 351–357. 13 indexed citations
9.
Lambracht‐Washington, Doris, Kevin C. O’Connor, Elizabeth Cameron, et al.. (2007). Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS. Journal of Neuroimmunology. 186(1-2). 164–176. 40 indexed citations
10.
Harp, Christopher, Jane Lee, Doris Lambracht‐Washington, et al.. (2006). Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection. Journal of Neuroimmunology. 183(1-2). 189–199. 48 indexed citations
11.
Cameron, Elizabeth & F. Richard Ferraro. (2004). Body Satisfaction in College Women after Brief Exposure to Magazine Images. Perceptual and Motor Skills. 98(3). 1093–1099. 21 indexed citations
12.
Hobbs, Stuart, Elizabeth Cameron, Robert P. Hammer, et al.. (2003). Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase. Oncogene. 23(4). 883–893. 23 indexed citations
13.
Hobbs, Stuart, Stephanie L. Coffing, Elizabeth Cameron, et al.. (2002). Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation. Oncogene. 21(55). 8442–8452. 70 indexed citations
14.
Douglas, Sara L., Michael D. Hill, & Elizabeth Cameron. (1989). Clinical Nurse Specialist. Clinical Nurse Specialist. 3(1). 12–15. 4 indexed citations
15.
Douglas, Sara L., Michael D. Hill, & Elizabeth Cameron. (1989). Clinical Nurse Specialist. Clinical Nurse Specialist. 3(1). 12–15. 12 indexed citations
16.
Cameron, Elizabeth, et al.. (1983). [Chronic hepatic encephalopathies. Acquired cerebral degeneration not due to Wilson's disease].. PubMed. 59(18). 1369–73. 3 indexed citations
17.
Wheeler, C. T., Elizabeth Cameron, & John C. Gordon. (1978). EFFECTS OF HANDLING AND SURGICAL TREATMENTS ON NITROGENASE ACTIVITY IN ROOT NODULES OF ALNUS GLUTINOSA, WITH SPECIAL REFERENCE TO THE APPLICATION OF INDOLE‐ACETIC ACID. New Phytologist. 80(1). 175–178. 15 indexed citations
18.
Cameron, Elizabeth, et al.. (1974). A familial neurological disease complex in a Bedfordshire community.. PubMed. 24(143). 435–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Medaer Breakdown of academic impact, for papers by Jacqueline Nicholas Breakdown of academic impact, for papers by Tobias Sejbæk Breakdown of academic impact, for papers by Elisabetta Verdun di Cantogno Breakdown of academic impact, for papers by V. Devonshire Breakdown of academic impact, for papers by J.A.P. Hiel Breakdown of academic impact, for papers by Dan Schaid Breakdown of academic impact, for papers by Ann Marie Weideman Breakdown of academic impact, for papers by Frida Lundmark Breakdown of academic impact, for papers by Brian Apatoff
Rankless by CCL
2026